Personalized cancer care: DNA profiling guides patients to best trials

NCT ID NCT02806388

Recruiting now Knowledge-focused Sponsor: National Cancer Centre, Singapore Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study analyzes the DNA of solid tumors from 5,500 cancer patients to find genetic changes that could be targeted by specific treatments. The goal is to use this molecular profile to match patients with appropriate clinical trials. Participants must have a confirmed solid tumor diagnosis and be able to provide a tissue sample.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors choose better treatments for cancer patients by matching them to the right clinical trials based on their tumor's genetic profile.
What could go wrong: This is an observational study, not a treatment trial. It may not directly benefit participants, and finding a matching trial does not guarantee the treatment will work.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID TUMOR

Contacts and locations

Locations

National Cancer Centre, Singapore
RECRUITING

Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.